What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Diabetes mellitus
Internal medicine, Gastroenterology, Nonalcoholic fatty liver disease, Cirrhosis and Fatty liver are his primary areas of study.
Leon A. Adams combines subjects such as Diabetes mellitus and Endocrinology with his study of Internal medicine.
Leon A. Adams has included themes like Liver transplantation, Surgery and Transplantation in his Gastroenterology study.
His Nonalcoholic fatty liver disease research includes elements of Cohort study, Liver disease, Biopsy, Hazard ratio and Cohort.
As part of one scientific family, Leon A. Adams deals mainly with the area of Cirrhosis, narrowing it down to issues related to the Liver function tests, and often Lipotoxicity.
Leon A. Adams works in the field of Fatty liver, namely Steatohepatitis.
His most cited work include:
- The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study (2181 citations)
- The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD (1634 citations)
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease (1266 citations)
What are the main themes of his work throughout his whole career to date?
Leon A. Adams mainly focuses on Internal medicine, Gastroenterology, Fatty liver, Nonalcoholic fatty liver disease and Cirrhosis.
His Internal medicine research focuses on subjects like Endocrinology, which are linked to Odds ratio.
He has researched Gastroenterology in several fields, including Hepatocellular carcinoma, Liver transplantation, Surgery and Metabolic syndrome.
His Fatty liver study integrates concerns from other disciplines, such as Diabetes mellitus and Insulin resistance.
The concepts of his Nonalcoholic fatty liver disease study are interwoven with issues in Immunology and Cohort.
His work carried out in the field of Cirrhosis brings together such families of science as Hepatitis C and Liver function tests.
He most often published in these fields:
- Internal medicine (106.01%)
- Gastroenterology (69.30%)
- Fatty liver (52.22%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (106.01%)
- Fatty liver (52.22%)
- Gastroenterology (69.30%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Fatty liver, Gastroenterology, Cirrhosis and Nonalcoholic fatty liver disease.
His work on Diabetes mellitus expands to the thematically related Internal medicine.
His Fatty liver research incorporates themes from Liver disease, Steatosis and Metabolic syndrome.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Metformin, Non alcoholic, Biopsy, Hazard ratio and Prospective cohort study.
His Cirrhosis research integrates issues from Liver transplantation, Bioinformatics and Confidence interval.
His research investigates the connection between Nonalcoholic fatty liver disease and topics such as Body mass index that intersect with problems in Cardiorespiratory fitness.
Between 2017 and 2021, his most popular works were:
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. (291 citations)
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study (212 citations)
- Noninvasive biomarkers in NAFLD and NASH - current progress and future promise. (138 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Disease
His primary scientific interests are in Internal medicine, Fatty liver, Gastroenterology, Cirrhosis and Fibrosis.
His study looks at the relationship between Internal medicine and fields such as Endocrinology, as well as how they intersect with chemical problems.
The study incorporates disciplines such as Chronic liver disease, Liver disease and Diabetes mellitus in addition to Fatty liver.
Leon A. Adams interconnects Lower risk, Confidence interval and Prospective cohort study in the investigation of issues within Gastroenterology.
Cirrhosis and Liver transplantation are frequently intertwined in his study.
His study in Fibrosis is interdisciplinary in nature, drawing from both Natural history and Liver biopsy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
